11.7
CiteScore
7.9
Impact Factor
Turn off MathJax
Article Contents

Lactylation at the crossroads: a metabolic-epigenetic-immune integrator in intestinal homeostasis and disease

doi: 10.1016/j.jgg.2026.10.010
Funds:

This research was funded by the National Natural Science Foundation of China (82370564).

  • Received Date: 2026-05-09
  • Accepted Date: 2026-10-17
  • Rev Recd Date: 2026-10-15
  • Available Online: 2026-10-30
  • Lysine lactylation (Kla) is a metabolite-sensitive post-translational modification implicated in DNA repair, tumorigenesis, chemoresistance, and innate immunity. Recent studies also implicate Kla in intestinal disorders. This review synthesizes current evidence on protein lactylation in intestinal inflammation, inflammatory bowel disease, colorectal cancer, irritable bowel syndrome, intestinal fibrosis, radiation-induced injury, and enteric infection. We distinguish lactate-mediated receptor signaling and metabolic effects from covalent Kla, compare evidence across cell types and disease stages, and assess preclinical strategies targeting the lactate-lactylation axis. We also discuss microbiota-host metabolic crosstalk and mucus-penetrating nanodelivery, including the cross-border emulsification effect, an oil-in-water double-emulsion concept that describes traversal of the mucus barrier rather than a biochemical form of lactylation. Collectively, the available evidence supports a metabolism-epigenetics-immunity framework for gut pathophysiology, while highlighting unresolved questions concerning stereochemistry, site specificity, causality, safety, and prospective clinical validation.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (39) PDF downloads (0) Cited by ()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return